Steven Goudy

Steven Goudy
steven.goudy@emory.edu

Steven L. Goudy, MD, MBA, professor of otolaryngology, director of pediatric otolaryngology at Emory University School of Medicine, founding director of the ACGME-accredited pediatric otolaryngology fellowship at Emory, and medical director of otolaryngology at Childrens Healthcare of Atlanta, is dedicated to providing top-level surgical care to the children of Georgia. 

His clinical practice focuses on maxillary development, Pierre Robin sequence, vascular malformations, and velopharyngeal insufficiency. Working closely with colleagues at the Centers for Disease Control and Prevention, Georgia Institute of Technology, and other local and state entities, Dr. Goudy and his team have developed novel and innovative solutions for care delivery that have brought value to families and improved treatment for patients. 

Dr. Goudys research is focused on defining the biologic processes that guide facial formation for the development of better approaches to regenerating damaged and deficient facial bone and improving wound healing after surgery or injury. Current research projects include an NIH-funded studies to develop immunological approaches to improving oral cavity wound healing, leveraging the oral microbiome to improve oral wound healing and a project to devise cranial facial bone regeneration techniques for pediatric bone replacement procedures. 

Dr. Goudy is dedicated to international service, particularly in the areas of surgical education and delivering surgical care to children with limited access to healthcare. He has traveled globally and performed mission work for more than 20 years in such countries as Guatemala and the Philippines, providing free surgical care to patients with cleft lip and cleft palate and engaging in medical education activities.

Associate Professor
Director, Division of Pediatric Otolaryngology Children's Healthcare of Atlanta
CEO, BeeClear LLC
Additional Research
Dr. Goudy’s lab focuses on craniofacial bone regeneration and the basic biologic mechanisms that control facial bone and soft tissue regeneration. He currently collaborates with investigators at Georgia Institute of Technology and is supported by the National Institutes of Health (NIH) and Children’s Research Trust.
University, College, and School/Department
LinkedIn Related Site
Steven
Goudy
L.
Show Regular Profile

Adam Klein

Adam Klein
aklein4@emory.edu

Adam M. Klein, MD, FACS, is Willard and Lillian Hackerman Professor in Voice in the Department of Otolaryngology at Emory University School of Medicine. Dr. Klein serves as Director of the Emory Voice Center and as Chief of the Division of Laryngology. Board certified with the American Board of Otolaryngology, Dr. Klein's clinical specialties include general otolaryngology, laryngeal disorders and the professional voice. 

Dr. Klein is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute. He is a Fellow of The American College of Surgeons and American Laryngological Association. He holds professional memberships with American Academy of Otolaryngology-Head and Neck Surgery, American Broncho-Esophagological Association, and Georgia Society for Otolaryngology.

Director, Emory Voice Center
Chief, Division of Laryngology
Willard and Lillian Hackerman Professor in Voice
Department of Otolaryngology - HNS
Phone
404-686-6774
Office
Emory University School of Medicine
Additional Research
Medical and Surgical Device Design, Development and Delivery
University, College, and School/Department
Related Site
Adam
Klein
M.
Show Regular Profile

Nicholas Boulis

Nicholas Boulis
nicholas.boulis@emoryhealthcare.org
Website

Dr. Nicholas M. Boulis is a neurosurgeon in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Emory University Hospital Midtown and Grady Memorial Hospital. He received his medical degree from Harvard Medical School and has been in practice for more than 20 years.

Associate Professor
MD
Director, Gene and Cell Therapy for Neurorestoration Laboratory
Phone
404-778-5770
Office
Emory Clinic, Building B
Additional Research
Boulis is a functional neurosurgeon with significant expertise in the field of gene transfer to the nervous system. Dr. Boulis' Gene and Cell Therapy Translational Laboratory pursues advanced biological treatments for neurological disorders, including Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease) and Spinal Muscular Atrophy (SMA).
University, College, and School/Department
Google Scholar
https://scholar.google.com/citations?hl=en&user=8xpt8YAAAAAJ&view_op=list_works&sortby=pubdate
LinkedIn Related Site
Nicholas
Boulis
Show Regular Profile

Robert Gross

Robert Gross
rgross@emory.edu
Website

Dr. Gross’s research interests include: restorative approaches (including cell and gene therapy) for Parkinson's disease and other neurodegenerative disorders; physiology of movement disorders (Parkinson's disease, tremor, dystonia); novel surgical techniques for epilepsy (e.g. deep brain stimulation, cell and gene therapy). In particular, he has been elucidating the role of axon guidance molecules in the development and reconstruction of the nigrostriatal pathway, which degenerates in P.D. This approach, which encompasses molecular and cellular engineering in combination with neurotransplantation, may be generally useful in reconstructive approaches for many types of nervous system degeneration and injury. 

In July of 2007, Dr. Gross, along with Steve M. Potter, Ph.D. of the Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, was the recipient of a prestigious grant from The Epilepsy Research Foundation (ERF) for translational research funding awards supporting innovative epilepsy products. The grant supports the development of a novel electrical stimulation approach that directly controls the activity of the brain to attain a more stable state from which seizures will not arise.

MBNA Bowman Chair & Professor
Director and Co-Founder, ENTICe
Director, Translational Neuro-Engineering Laboratory
Director, Stereotactic, Functional Neurosurgery & Epilespsy Surgery
Phone
404-727-2354
Office
Emory WMRB 6311
Additional Research
Neuromodulation using multielecrode arrays, closed loop control theory, and optogenetics for epilepsy and movement disorders. Computational modeling of epilepsy networks for model-based and non-model based feedback control of optogenetic and electrical neuromodulation. Neurorestoration using gene and cell-therapy based approaches for degenerative and injury conditions. The Translational Neuroengineering Research Lab uses neuromodulation for epilepsy using a combination of the following advanced techniques: 1) Multimicroelectrode electrical stimulation using novel parameters informed by optimization of input/output relationships (both model- and non-model based MIMO) using closed-loop control theory including adaptive learning and machine learning approaches; 2) Optogenetic activation and inhibition using all forms of available channels including step-function opsins. These approaches identify novel brain regions that have more widespread control and targets specific cell types for activation and inhibiton. Closed loop control using multielecrode arrays informs and controls neuromodulation. 3) Hardware independent 'luminopsins': novel gene therapy approaches combining bioluminescent proteins with optogenetic channels for hardware independent, widespread and activity-regulatable neuromodulation. We use a combination of in vitro models, animal models (mouse, rat, non-human primate) and human patients undergoing epilepsy and deep brain stimulation surgery as our experimental models. In addition, the laboratory has developed novel gene therapy vectors for neurorestoration targeting key pivotal proteins regulating axon outgrowth in regenerative situations, including for Parkinson's disease, spinal cord injury and retinal degeneration.
Research Focus Areas
University, College, and School/Department
Google Scholar
https://scholar.google.com/citations?user=HR5pAakAAAAJ&hl=en&oi=ao
Related Site
Robert
Gross
Show Regular Profile

Edmund Waller

Edmund Waller
ewaller@emory.edu
Website

Dr. Waller specializes in bone marrow transplants for acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, aplastic anemia, sickle cell disease and in the management of graft-versus-host disease.

Professor of Medicine, Medical Oncology and Pathology
Rein Saral Professor of Cancer Medicine
Interim Associate Director, Clinical Research, Winship Cancer Institute
Medical Director, Center for Stem Cell Processing and Apheresis
Director, Emory Regenerative Engineering and Medicine Center
Phone
404-778-2984
Office
Winship Cancer Institute of Emory University
Additional Research
Dr. Waller's research focus is in enhancing immune reconstitution after stem cell transplant and developing cell and small-molecule based cancer immunotherapeutics. His current research activities include pre-clinical and clinical studies focused on the role of donor immune cells in optimizing anti-tumor immunity after allogenic transplantation, enhancing functional properties of chimeric-antigen-receptor T cells, and blocking novel immune check-point pathways in cancer. His NIH-funded basic and translational research lab uses mouse models and performs immunological analyses of clinical samples from patients. He has active translational research activities and serves as a principal investigator on institutional and national cooperative group clinical trials.
University, College, and School/Department
Google Scholar
https://scholar.google.com/citations?user=ZwhScmYAAAAJ&hl=en
LinkedIn Related Site
Edmund
Waller
K.
Show Regular Profile

David Lynn

David Lynn
dlynn2@emory.edu
Website

David G. Lynn has contributed in the general areas of molecular recognition, synthetic biology and chemical evolution, and has developed chemical and physical methods for the analysis of supramolecular self-assemblies, of signal transduction in cellular development and pathogenesis, of molecular skeletons for storing and reading information, and of the evolution of biological order.

Lynn has earned a Howard Hughes Medical Institute Professorship, the Emory Scholar-Teacher Award, a fellowship from the American Association for the Advancement of Science, and the ACS Charles H. Herty Medal.

During his tenure as Chair of the Department of Chemistry from 2006-2015, Lynn assisted in the renovation of the Atwood chemistry building. In 2018 and 2019, Lynn also served as a board member for the Atlanta Science Festival.

Asa Griggs Candler Professor
Howard Hughes Medical Institute Professor
Phone
404-727-9348
Office
Emerson E407
Additional Research
The David G. Lynn Group at Emory University works to understand the structures and forces that enable supramolecular self-assembly, how chemical information can be stored and translated into new molecular entities, and how the forces of evolution can be harnessed in new structures with new function. Some of our current research areas include the origins of prokaryotic and eukaryotic pathogenesis, template directed polymerization and dynamic combinatorial systems, amyloid diseases and protein self-assembly, and intelligent materials.
Research Focus Areas
University, College, and School/Department
Google Scholar
http://scholar.google.com/scholar?q=david+g+lynn&btnG=&hl=en&as_sdt=0,11
David
Lynn
Show Regular Profile

Khalid Salaita

Khalid Salaita
k.salaita@emory.edu
Website

Khalid Salaita is the Samuel Candler Dobbs Professor of Chemistry, and Director for Graduate Studies in the Chemistry Department at Emory University in Atlanta, Georgia (USA). Khalid grew up in Jordan and moved to the US in 1997 to pursue his undergraduate studies at Old Dominion University in Norfolk, Virginia (USA). He worked under the mentorship of Prof. Nancy Xu studying the spectroscopic properties of plasmonic nanoparticles. He then obtained his Ph.D. with Prof. Chad Mirkin at Northwestern University (Evanston, IL) in 2006. 

During that time, he studied the electrochemical properties of organic adsorbates patterned onto gold films and developed massively parallel scanning probe lithography approaches. From 2006-2009, Khalid was a postdoctoral scholar with Prof. Jay T. Groves at the University of California at Berkeley (USA) where he investigated the role of receptor clustering in modulating cell signaling. In 2009, Khalid started his own lab at Emory University, where he is currently investigating the use of nucleic acids as molecular force sensors, smart drugs, and synthetic motors. 

In recognition of his independent work, Khalid has received a number of awards, most notably: the Alfred P. Sloan Research Fellowship, the Camille-Dreyfus Teacher Scholar award, the National Science Foundation Early CAREER award, the Kavli Fellowship, and Merck Future Insight Prize. Khalid is currently the director of the Center on Probes for Molecular Mechanotechnology, and an Associate Editor of SmartMat. Khalid’s program has been supported by NSF, NIH, and DARPA.

Associate Professor
Samuel Candler Dobbs Professor of Chemistry
Director for Graduate Studies in the Chemistry Department
Program Faculty in the Department of Biomedical Engineering at Emory University and Georgia Institute of Technology
Phone
404-727-7522
Office
506 Atwood
Additional Research
In 2009, Khalid started his own lab at Emory University, where he currently investigates biophysical aspects of receptor-mediated cell signaling. To achieve this goal, his group has pioneered the development of molecular force probes and nano-mechanical actuators that are integrated with living cells. These materials are used to investigate the molecular mechanisms of a number of pathways where piconewton forces are thought to be important. These pathways include the Notch-Delta pathway, T cell receptor activation and the integrin-based focal adhesion pathway.
University, College, and School/Department
Google Scholar
https://scholar.google.com/citations?user=ZNhXzgIAAAAJ&hl=en
LinkedIn
Khalid
Salaita
Show Regular Profile

William Brent Keeling

William Brent Keeling
brent.keeling@emory.edu

Dr. Keeling earned his medical degree at the University of Louisville in 2001, did his general surgery residency at the University of South Florida School of Medicine from 2001-2008, and completed his cardiothoracic surgery fellowship at Emory in 2011. Dr. Keeling directs the cardiothoracic surgery program at Grady Memorial Hospital and provides clinical service at Emory University Hospital Midtown. His clinical interests include reoperative cardiac surgery, valve repair and thoracic aortic pathology, and his research focuses on clinical trials as well as data-driven investigations of adult cardiac surgical sub-populations.

Assistant Professor of Surgery, Division of Cardiothoracic Surgery
Chief, Cardiothoracic Surgery Service, Grady Memorial Hospital
Phone
404-616-0539
Additional Research
Targeted clinical investigations of adult cardiac surgical sub-populations.
Research Focus Areas
University, College, and School/Department
LinkedIn Related Site
William Brent
Keeling
Show Regular Profile

Mara Schenker

Mara Schenker
m.schenker@gmail.com

Mara Schenker, MD is a clinician-scientist at Emory University. Her clinical practice is in orthopaedic trauma at Grady Memorial Hospital, and her interests include complex periarticular trauma, infection, nonunion, and malunion. Dr. Schenker performs approximately 600 complex trauma surgeries per year. Her research interests include host factors associated with delayed fracture healing (nutrition, infection, frailty, and others). Additional research interests include optimization of resident education.

Associate Professor
Director of Orthopaedic Trauma Research
Phone
404-778-1550
Office
Grady Memorial Hospital
University, College, and School/Department
Google Scholar
https://scholar.google.com/citations?user=EV_I70oAAAAJ&hl=en
LinkedIn
Mara
Schenker
Show Regular Profile

Gary J. Bassell

Gary J. Bassell
gbassell@emory.edu
Website

Gary J. Bassell, Ph.D. joined the faculty at Emory University School of Medicine in 2005, where he is currently Professor and Chair of the Department of Cell Biology. His personal lab’s main interest is in understanding the mechanisms and functions of mRNA transport and local protein synthesis in neurons of the central and peripheral nervous system. The lab utilizes in vitro and in vivo mouse models and induced pluripotent stem cells (iPSCs) to study the basic mechanism, regulation and function of mRNA localization and local translation in axonal growth cones and dendritic spines. Prior to moving Emory, Dr. Bassell was a member of the faculty at the Albert Einstein College of Medicine, in the Department of Anatomy and Structural Biology (1995-1998) and subsequently in the Department of Neuroscience and Rose Kennedy Center for Mental Retardation (1998-2005). 

Professor and Chair of the Department of Cell Biology
Emory University
Phone
404-727-3772
Office
Whitehead Biomedical Research Bldg. #405E
Additional Research
The research interests of our laboratory are to understand the diverse and critical roles played by mRNA binding proteins and associated factors in the posttranscriptional regulation of gene expression in the nervous system, and investigate how these processes go awry in neurodevelopmental and neurodegenerative disorders. We investigate the normal mechanism, function and regulation of mRNA binding proteins in mRNA transport and local protein synthesis needed for neuronal development and synaptic plasticity. We investigate pathomechanisms for Fragile X syndrome (FXS) and other autism spectrum disorders, as well as two motor neuron diseases: spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). We are using mouse models of neurological diseases to assess the function of mRNA regulation and local protein synthesis in axon guidance, synapse development and neuronal signaling. Efforts are also underway to evaluate different therapeutic modalities in these mouse models of neurological diseases. Our research utilizes an integrated multi-disciplinary approach that involves cellular, molecular, biochemical, physiological, and behavioral methods and paradigms. These studies are expected to reveal new mechanisms important for neuronal development and function, and targeted approaches for therapeutic intervention that treat underlying molecular defects in SMA, Fragile X syndrome and autism spectrum disorders.
Research Focus Areas
University, College, and School/Department
Related Site
Gary
Bassell
J.
Show Regular Profile